BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4826131)

  • 1. [Controlled clinical trial of arginine malate associated with cytidine and uridine in secondary hepatopathies].
    Rampazzo F
    Minerva Med; 1974 Feb; 65(15):838-49. PubMed ID: 4826131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of arginine-malate associated with cytidine and uridine adminstered high doses by intravenous way in gestoses of the 3d trimester. Results of controlled clinical experimentation].
    Viozzi A; Marchetti M; Fais G
    Minerva Ginecol; 1974 Nov; 26(11):647-56. PubMed ID: 4614124
    [No Abstract]   [Full Text] [Related]  

  • 3. [High-dose intavenous administration of arginine-malate combined with cytidine and uridine in the treatment of chronic liver diseases].
    Barlattani M; De Martiis M; Messina B
    Clin Ter; 1974 Aug; 70(4):323-36. PubMed ID: 4609677
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of arginine malate in experimental and clinical hyperammonemia].
    Szãm I; Szentner J; Hegedüs-Wein I; Vass A
    Int J Clin Pharmacol; 1972 Aug; 6(3):260-5. PubMed ID: 4648469
    [No Abstract]   [Full Text] [Related]  

  • 5. [Controlled clinico-statistical studies on the role of the nucleosides in an association of hepatoprotective and anti-asthenic action].
    Soranzo ML
    Minerva Med; 1974 Feb; 65(8):391-7. PubMed ID: 4820721
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adrenocortical extract, liver extract and nucleosides as metabolism-stimulating antianemic and liver protecting agents].
    Tolva D
    Minerva Med; 1973 Dec; 64(89):4692-7. PubMed ID: 4775168
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical trial of liver-protective agents containing cytidine and uridine in the therapy of patients with liver diseases].
    Grimaldi N; Santoro C
    Policlinico Med; 1971; 78(3):134-46. PubMed ID: 5568445
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of short-term administration of cytidine, uridine and levoglutamine, alone or in combination, on the cerebral electrical activity of patients with chronic cerebrovascular disease.
    Manna V; Martucci N
    Int J Clin Pharmacol Res; 1988; 8(3):199-210. PubMed ID: 3403106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nucleosides in the therapy of hepatopathies].
    Urbinati GC
    Clin Ter; 1966 Oct; 39(1):39-54. PubMed ID: 5998856
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic action of arginine-thiazolidine-carboxylate (ATCA) as evaluated by liver function tests].
    Alvisĭ V; D'Ambrosi A; Lo Ponte A; Tampieri ML; Tralli M
    Arch Sci Med (Torino); 1980; 137(4):731-8. PubMed ID: 7018458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled clinical trial of a new combination of phosphorylcholine, homocysteine-gamma-thiolactone and vitamin B 12 in the parenteral treatment of chronic hepatopathies].
    Bandini S; Monteforte S
    Clin Ter; 1974 Jun; 69(6):549-60. PubMed ID: 4845637
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the use of liver extracts enriched with uridine, cytidine and vitamin B 12 in pediatric therapy].
    Rizzo A
    Minerva Pediatr; 1971 May; 23(18):803-10. PubMed ID: 5090393
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cholesterolemic changes after treatment with a new hepatoprotective drug in geriatric patients].
    Baldoni E; Floris E; Nuzzo L
    G Gerontol; 1968 Aug; 16(8):785-7. PubMed ID: 5740953
    [No Abstract]   [Full Text] [Related]  

  • 15. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytidine and uridine nucleosides in vascular encephalopathies (preliminary report)].
    Cervantes León G; González-González J; Padilla Nibra J
    Neurol Neurocir Psiquiatr; 1970; 11(1):11-8. PubMed ID: 5527965
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the postoperative treatment of liver damages in surgical patients].
    Schellenberger A; Gürtner T; Hart W; Lick RF
    Chirurg; 1966 Jun; 37(6):244-8. PubMed ID: 5995038
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations on the treatment with the combination of ribonucleosides, hepatic extract and vitamin B-12 (Nuclepatox) of acute and chronic liver diseases in the course of pulmonary tuberculosis].
    Ravazzoni C; Balzano E; Cuneo S
    Minerva Med; 1967 Jan; 58(6):141-7. PubMed ID: 6016918
    [No Abstract]   [Full Text] [Related]  

  • 19. [Simultaneous HPLC determination of cytidine, uridine and arginine malate].
    Campadello D; Levorato C
    Farmaco Prat; 1985 Nov; 40(11):383-7. PubMed ID: 4076413
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the treatment of various liver diseases by oral administration of arginine glucose-1-phosphate].
    Arrigo A
    Clin Ter; 1967 Dec; 43(6):523-41. PubMed ID: 5617980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.